ProFound Therapeutics
Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia
$35MStrategic
Role not disclosedGF
Gates Foundation
Activity from announced rounds
Activity in this selectionallina-health-258a8846
- Rounds participated in
- 6
- Confirmed lead rounds
- — 6 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $178.3M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in this selectionLeyden Laboratories
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
€40MSeries B
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedTen63 Therapeutics
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
$45MStrategic
Role not disclosedHeritable Agriculture
Develops AI-driven crop improvement solutions for climate-resilient crops
$5MGrant
Role not disclosedQure.ai
Develops AI-powered diagnostic solutions for early detection and care management of diseases
UndisclosedGrant
Role not disclosed